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Background: Little information is available the role of Nitric 
Oxide (NO) in host defenses during human tuberculosis (TB) 
infection. We investigated the modulating factor(s) affecting 
NO synthase (iNOS) induction in human macrophages. 
Methods: Both iNOS mRNA and protein that regulate the 
growth of mycobacteria were determined using reverase 
transcriptase-polymerase chain reaction and western blot 
analysis. The upstream signaling pathways were further in-
vestigated using iNOS specific inhibitors. Results: Here we 
show that combined treatment with 1,25-dihydroxyvitamin 
D3 (1,25-D3) and Interferon (IFN)-γ synergistically en-
hanced NO synthesis and iNOS expression induced by 
Mycobacterium tuberculosis (MTB) or by its purified protein 
derivatives in human monocyte-derived macrophages. Both 
the nuclear factor-κB and MEK1-ERK1/2 pathways were 
indispensable in the induction of iNOS expression, as shown 
in toll like receptor 2 stimulation. Further, the combined treat-
ment with 1,25-D3 and IFN-γ was more potent than either 
agent alone in the inhibition of intracellular MTB growth. 
Notably, this enhanced effect was not explained by increased 
expression of cathelicidin, a known antimycobacterial effec-
tor of 1,25-D3. Conclusion: These data support a key role of 
NO in host defenses against TB and identify novel modulat-
ing factors for iNOS induction in human macrophages.
[Immune Network 2009;9(5):192-202]
INTRODUCTION
Mycobacterium tuberculosis (MTB) is the greatest single in-
fectious cause of mortality worldwide, killing roughly 2 mil-
lion people per year. Estimates indicate that one-third of the 
world’s population is infected with latent MTB. The synergy 
between  tuberculosis  (TB)  and  the  AIDS  epidemic  and  the 
surge in multidrug-resistant clinical isolates of MTB have re-
affirmed TB as a primary public health threat. The develop-
ment of new antituberculous agents could have a profound 
impact  on  TB  therapy  and  on  world  health  (1).
    The  high-output  expression  of  nitric  oxides  (NO)  in  re-
sponse to cytokines or to pathogen-derived molecules is an 
important  component  in  host  defenses  against  intracellular 
microorganisms as diverse as Toxoplasma gondii, Leishmania 
major, Listeria monocytogenes, Plasmodium species, Ectrome-
lia  virus,  Coxsackie  B3  virus,  M.  leprae,  and  MTB  (2).  In 
mice,  the  induction  of  NO  and  nitric  oxide  synthase-2 
(NOS2)-derived  reactive  nitrogen  intermediates  in  macro-
phages is a major effector mechanism for antimycobacterial 
action (3). There are conflicting reports as to whether human 
monocytes/macrophages are able to kill MTB in an iNOS-de-
pendent manner; nevertheless, NO might play an important 
r o l e  i n  r e s i s t a n c e  t o  M T B  i n f e c t i o n ,  a s  s e e n  i n  b o t h  e x -
perimental  and  human  TB  (4-8).
    Although  little  research  has  addressed  modulating  factors 
acting on human iNOS and NO synthesis, it has been reported 
that  the  human  promyelocytic cell  line  HL-60,  when  differ-
entiated to a macrophage-like phenotype, acquires the ability 
to produce substantial amounts of NO upon stimulation with 
lipopolysaccharides (LPS) or with 1, 25-dihydroxyvitamin D3 
(1,25-D3) (9). Of note, a recent study by Liu et al. (10) dem-
onstrated  that  toll-like  receptor  (TLR)  activation  in  human Nitric Oxide Synthesis in Human Macrophages
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macrophages  up-regulated  the  expression  of  the  vitamin  D 
receptor and vitamin D-1-hydroxylase genes, leading to the 
induction of the antimicrobial peptide cathelicidin, and thus 
killing intracellular MTB (10). Despite efforts to examine the 
functions of NO and inducing factors in human cells, there 
is  no  efficient  method  of  inducing  iNOS  in  human  macro-
phages i n  v i t r o   (11).
    In  the  present  study,  we  found  that  combined  treatment 
with 1,25-D3 and interferon (IFN)-γ synergistically enhanced 
NO release and iNOS expression induced by MTB or its puri-
f i e d  p r o t e i n  d e r i v a t i v e s  ( P P D)  in  human  monocyte-derived 
macrophages (MDMs). In addition, the activation of the nu-
clear factor (NF)-κB and MEK1-ERK1/2 pathways was essen-
tial  for  iNOS  gene  expression  in  these  cells  and  required 
TLR2. Finally, this combined regimen significantly suppressed 
the growth of MTB in MDMs, suggesting an important role 
of  NO  in  host  defense  against  TB.
MATERIALS AND METHODS
Reagents
Single-cell suspension cultures of MTB H37Ra (ATCC 25177) 
and  MTB  H37Rv  (kindly  provided  by  Dr.  Richard  L. 
Friedman, University of Arizona, Tucson, AZ) were prepared 
as described previously (12). The tuberculin PPD used in the 
in  vitro  assays  was  purchased  from  Statens  Serum  Institut 
(Copenhagen,  Denmark)  and  was  used  at  a  final  concen-
tration  of  5.0  μg/ml. 
    LPS, 1,25-D3, N
G-monomethyl-L-arginine (L-NMMA, a non-
selective NOS inhibitor), and N
G-nitro-L-arginine methyl ester 
(L-NAME) were purchased from Sigma (St Louis, MO). Mouse 
anti-human TLR2 mAb (clone TL2.1, IgG2a), mouse anti-hu-
man TLR4 mAb (clone HTA125, IgG2a), and isotype control 
( I C )  m A b  ( I g G 2 a )  w e r e  p u r c h a s e d  f r o m  e B i o s c i e n c e  ( S a n  
Diego, CA). Specific antibodies  against  extracellular-regulat-
ing kinase (ERK) 1/2, phospho-(Thr202/Tyr204)-ERK1/2, p38, 
phospho-(Thr180/Tyr182)-p38,  and  phospho-IKKα/β were 
purchased from Cell Signaling Technology. Antibody against 
iNOS  Ab  (IgG),  β-actin,  IκB-α (IgG1),  and  MEK-1  mAb 
(H-8, IgG2b) were obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA). The specific inhibitors U0126 for MEK, caf-
feic  acid  phenethyl  ester  for  NF-κB  (CAPE),  BAY  11-7082 
for  IκB-α  phosphorylation,  and  SB203580  for  p38  mi-
togen-activated protein kinase (MAPK) were obtained  from 
Calbiochem (San Diego, CA). Recombinant human (rh) IFN-γ 
and  rhtumor  necrosis  factor  (TNF)-α were  obtained  from 
R&D  systems  (Minneapolis,  MN).  The  psiRNA-h7SKGFPzeo 
plasmids  for  generating  hTLR2  or hTLR4 short  hairpin RNA 
(shRNA)  were  obtained  from  Invitrogen  (Carlsbad,  CA). 
Transfection  of  these  plasmids  into  human  primary  MDMs 
was  performed  using  amaxa  Nucleofector  technology 
(Gaithersburg, MD). Protein A-Sepharose for the MEK-1 assay 
was obtained  from Amersham Bioscience (Freiburg, Germa-
ny),  and  [γ-
32P]-ATP  was  obtained  from  PerkinElmer  (San 
Jose,  CA).
Culture of human MDMs 
This study was approved by the local Ethical Committee of 
Konyang University Hospital’s review board, which oversees 
studies on samples from human subjects. Healthy volunteers 
provided informed written consent to take part in this study. 
Adherent  monocytes  were  collected  from  peripheral  blood 
mononuclear cells donated by healthy subjects, as previously 
described (12). Human MDMs were prepared by culturing pe-
ripheral blood monocytes for 4∼5 days in the presence of 
0.2  ng/ml  human  macrophage  colony-stimulating  factor 
(Sigma). In order to show that the stimulatory capacity of my-
cobacteria was not the result of contamination with LPS, ex-
periments  were  performed  that  by  addition  of  the  specific 
LPS-inhibiting oligopeptide polymyxin B (10 μg/ml) before 
mycobacterial stimulation. To assess their sensitivity to rhIFN-
γ and 1,25-D3, human MDMs were incubated in the pres-
ence  of  these  factors  then  stimulated  with  PPD  or  MTB. 
Detection of NO and nitrites
The detection of NO was detected with minor modifications 
using the NO-sensitive fluorescent probe DAF-2 DA (Calbio-
chem)  and  laser-scanning  confocal  microscopy  (model  LSM 
510, Zeiss), as described previously (13). NO production was 
also measured indirectly as nitrite accumulation in cell culture 
medium  by  using  the  Griess  reaction  (14).
Reverse transcriptase-PCR and Western blots
Human  MDMs were  treated  as  indicated  and  processed  for 
analysis  by  reverase  transcriptase-polymerase  chain  reaction 
(RT-PCR) and western blot, as described previously (12). RT- 
PCR for human iNOS mRNA was performed after total RNA 
was  extracted  from  the  cells  using  TRIzol  (Invitrogen).  For 
Western blot analysis, antibodies to phosphorylated and total 
p38,  JNK,  ERK1/2,  and  β-actin  were  used  at  1：1,000 
dilutions. Specific bands were developed by ECL (Amersham 
Biosciences). Nitric Oxide Synthesis in Human Macrophages
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In vitro MEK assay
Confluent MDMs were infected with MTB in the presence or 
absence of pre-treatment of either IFN-γ or 1,25-D3 alone, 
or their combination. After incubation, the cells were lysed 
with  ice-cold  lysis  buffer  and  in vitro  MEK  assay  was  con-
ducted, as previously described (12). The gel was dried and 
autoradiography  was  performed  to  visualize  the 
32P-labeled 
MBP. Densitometry was performed on films and the fold in-
crease was calculated as experimental sample/control sample.
Quantification of mycobacterial growth
For the quantification of intracellular Mtb, we employed two 
independent methods (15). For colony-forming units (CFUs) 
assay, the cells were lysed with 0.3% saponin (Sigma Chemi-
cal) to release the intracellular bacteria, after various periods 
of incubation. The lysates of the infected cells were sonicated 
i n  a  p r e h e a t e d  3 7
oC  water  bath  sonicator  (Elma,  Singen, 
Germany) for 5 min. Aliquots of the sonicates were then di-
luted tenfold in 7H9 medium. Four dilutions of each sample 
were plated separately on 7H10 agar plates and incubated at 
37
oC with 5% CO2 for 21 days. For [
3H] uracil incorporation 
assays,  the  cells  were  lysed  then  transferred  to  96-well 
round-bottom plates and incubated in the presence of 1 μCi 
[
3H] uracil (Amersham-Pharmacia). After 24 h, the mycobac-
teria were killed by treatment with paraformaldehyde (final 
concentration,  4%)  for  30  min.  [
3H]uracil  incorporation  was 
m e a s u r e d  u s i n g  a  b e t a  c o u n t e r  ( B e r t h o l d ,  M ünchen, 
Germany).
Statistical analysis 
Data obtained from independent experiments are presented 
as  the  mean±SD  and  were  analyzed  using  either  paired 
t-tests  with  Bonferroni  adjustment  or  ANOVA  for  multiple 
comparisons. Differences were considered significant at p＜ 
0.05.
RESULTS
Effects of rhIFN-γ  and rhTNF-α  on PPD-induced 
nitrite production and iNOS expression
To address the role of NO during mycobacterial infection in 
human cells, we first characterized the pattern of in vitro NO 
production  and  iNOS  expression  in  primary  human  MDMs 
( F i g .  1 ) .  U p o n  s t i m u l a t i o n  w i t h  t h e  P P D  a n t i g e n  o f  M T B  
H37Ra,  human  primary  MDMs  exhibited  very low  levels of 
nitrite production as measured by Griess nitrite assays, with 
accumulated  nitrite  levels  below  10μM  after  at  96-h  in-
cubation (Fig. 1A). There was no cytotoxicity in cells cultured 
for 168 h (data not shown). Human iNOS gene induction by 
PPD in MDMs reached a peak at 6 h, based on RT-PCR analy-
sis  (Fig.  1B).  Given  that  rhIFN-γ and  rhTNF-α stimulate 
macrophages to upregulate the expression of iNOS in mice 
(16), the effects of these stimuli were examined on nitrite pro-
duction in human MDMs. As clearly shown in Fig. 1C, the 
addition of IFN-γ (10 ng/ml), TNF-α (10 ng/ml), or a com-
bination of both failed to increase the nitrite levels in human 
M D M s  a f t e r  P P D  t r e a t m e n t .  I n  a d d i t i o n ,  t h e r e  w a s  n o  s i g -
nificant increase in nitrite levels after combined treatment of 
IFN-γ and TNF-α, when compared with those cultured with 
media  control  (data  not  shown).  These results  suggest  that 
neither IFN-γ nor TNF-α influence the up-regulation of ni-
trite production in human MDMs, as has been reported pre-
viously  (17).
Synergistic effect of IFN-γ  and 1,25-D3 on NO 
production and iNOS expression in human primary 
MDMs
Several lines of evidence indicate that 1,25-D3 regulates host 
resistance  to  MTB.  In  addition  to  its  function  in  the  ex-
pression of the antimicrobial peptide cathelicidin (10), the vi-
tamin D receptor triggered by 1,25-D3 is also involved in the 
production of substantial amounts of NO in the human pro-
myelocytic cell line HL-60, when the cells are differentiated 
to a macrophage-like phenotype (9). To confirm the sensi-
tivity of NO production to IFN-γ and 1,25-D3, we incubated 
human primary MDMs in the presence of these two factors. 
A s s ho w n in  F ig .  2 A,  1 , 2 5- D 3 or  IF N -γ alone scarcely in-
duced an increase in nitrite production after 10 days in cul-
ture with PPD. However, the combined treatment with IFN-γ 
and 1,25-D3 led to a significant increase in nitrite production 
by human MDMs (p＜0.001 vs. IFN-γ or 1,25-D3 alone on 
day 10 in culture with PPD; Fig. 2A). In addition, combined 
stimulation with IFN-γ and 1,25-D3 induced a significant and 
synergistic increase in NO production, as measured with the 
NO-sensitive fluorescent probe DAF-2 DA (p＜0.001 vs. IFN-
γ or 1,25-D3 alone; Fig. 2B). Furthermore, we tried to exam-
ine  whether  similar  effects  were  detected  in  cells  cultured 
with MTB H37Ra. As shown in Fig. 2C, combined stimulation 
with  IFN-γ and  1,25-D3  induced  a  significant  increase  in 
iNOS protein expression in human MDMs treated with MTB 
H37Ra  (Fig.  2C).  The  nitrite  production,  and  expression  of 
iNOS and NO were significantly  attenuated by  pretreatment Nitric Oxide Synthesis in Human Macrophages
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Figure 1. Nitrite production and iNOS mRNA expression by PPD in 
human monocyte-derived macrophages (MDMs). MDMs were 
pretreated with TNF-α (10 ng/ml), or IFN-γ (10 ng/ml), alone or in
combination, for 18 h.  The following pretreatment, PPD (5 μg/ml) 
was added to all cultures. (A) Kinetics of PPD-induced nitrite 
production. (B) Analysis of  iNOS mRNA expression after PPD 
treatment. Upper panel, Representative gel from three independent 
experiments with similar results is shown. Lower panel, Densitometric
assessment of three independent replicates (for each experiment) with
similar results. (C) Effect of IFN-γ, TNF-α, or both on PPD-induced
nitrite production at 96 h. Results are representative of three 
experiments. *p<0.05, **p<0.01 vs. untreated control.
with  either  L-NMMA  or  L-NAME,  both  of  them  commonly 
used competitive inhibitors of NO synthase (Fig. 2A∼C). In 
all experiments, we found that the effects of combined stim-
ulation with IFN-γ and 1,25-D3 without PPD or MTB H37Ra 
were  negligible  for  induction  of  iNOS  expression  or  nitrite 
production (data not shown). Therefore, this combined stim-
ulation efficiently up-regulated human iNOS and NO in hu-
man  macrophages. 
The roles of ERK1/2 and NF-κB in iNOS activation 
induced by IFN-γ and 1,25-D3
We next investigated the molecular mechanism by which IFN-
γ and 1,25-D3 induce iNOS activation. Previous studies re-
ported  that  MAPKs  and  NF-κB  regulate  the  expression  of 
iNOS genes (18,19). Thus, we first tested whether incubation 
with IFN-γ, 1,25-D3, or both affected the activation of NF-κB 
in  MTB  H37Ra  -treated  human  macrophages.  As  shown  in 
Fig. 3A, the expression level of IκB-α was dramatically atte-
nuated in MDMs following combined treatment for 30 min. 
In  contrast,  there  was  a  remarkable  increase  in  the  MTB 
H37Ra-induced phosphorylation of IKKα/β in cells primed 
with  IFN-γ and  1,25-D3,  compared  with  untreated  control 
cells or cells treated with IFN-γ or 1,25-D3 alone (Fig. 3A). 
Exposure  to  MTB  H37Ra  led  to  strong  phosphorylation  of 
ERK1/2  and  p38  MAPK  in  human  MDMs  at  30  min  after 
stimulation. Although the addition of IFN-γ or 1,25-D3 alone 
had no effect, their combined treatment up-regulated phos-
p h o - E R K 1 / 2  b u t  n o t  p h o s p h o - p 3 8  ( F i g .  3 B ) .  I n  a d d i t i o n ,  a 
similar up-regulation of MEK1 activity was observed in MDMs 
primed  with  IFN-γ plus  1,25-D3  (Fig.  3C).
    Notably,  these  separate  responses  (NF-κB,  ERK1/2,  and 
p38)  were  correspondingly  blocked  by  the  NOS  inhibitors Nitric Oxide Synthesis in Human Macrophages
Ji-Sook Lee, et al.
196 IMMUNE NETWORK http://www.ksimm.or.kr Volume 9 Number 5 October 2009
Figure 2. 1,25-D3 synergizes with IFN-γ to increase NO, nitrite, and iNOS protein levels in human monocyte-derived macrophages (MDMs). 
MDMs were pretreated with IFN-γ, or 1,25-D3 (20 nM), alone or in combination, for 18 h, with or without L-NMMA (100 μM) or L-NAME 
(100  μM). Following pretreatment, PPD  or MTB H37Ra (MOI = 1) was added to all cultures. (A) Effect of IFN-γ, 1,25-D3, or both on 
PPD-induced nitrite production over time (at 1, 4, and 10 days). (B) PPD-induced NO generation in human MDMs pretreated with IFN-γ, 1,25-D3,
or both. The generation of NO was detected by staining with DAF-2 DA (10 μM) for 1 h and monitored by confocal microscopy. Upper panel,
representative immunofluorescence. Lower panel, quantitative analysis (C) Expression of iNOS protein by MTB H37Ra-stimulated MDMs pretreated 
with IFN-γ, 1,25-D3, or both at 6 h. Western blot analysis was performed using rabbit anti-iNOS Ab. Results are representative of three 
experiments. ***p＜0.001 vs. PPD-treated control.
L-NAME and L-NMMA (Fig. 3A∼C), indicating that iNOS in-
duction activates the NF-κB and MAPK pathways in human 
MDMs. Further, inhibition of MEK1 with U0126 or NF-κB in-
hibition with specific inhibitors (CAPE and BAY11-7082) (20) 
reduced  MTB-induced  iNOS  expression  in  human  MDMs 
primed with IFN-γ and 1,25-D3, in a dose-dependent man-
ner  (Fig.  3D).  The  inhibition  of  p38  MAPK  with  SB203580 
or JNK1/2 inhibition with SP600125 did not significantly di-
minish iNOS mRNA expression (Fig. 3D and data not shown). 
The results of these experiments indicate that the activation 
of  ERK1/2  and  NF-κB  is  necessary  for  the  modulation  of 
iNOS  by  combined  IFN-γ and  1,25-D3  treatment. 
TLR2 plays an indispensable role in MTB-stimulated 
iNOS induction in human MDMs
It  has  been  demonstrated  that  TLR2  plays  an  essential  role 
in  iNOS  induction  in  vivo  (21).  However,  there  have  been 
no reports about its role in iNOS mRNA expression in human 
monocytes/macrophages during MTB infection. We evaluated 
the roles of TLR2 and TLR4 in MTB H37Ra- or PPD-induced 
iNOS expression after combined treatment with IFN-γ and 
1,25-D3 in human monocytes or in MDMs. In the representa-Nitric Oxide Synthesis in Human Macrophages
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Figure 3. iNOS expression induced by IFN-γ and 1,25-D3 involves NF-κB or the ERK1/2 pathway. (A∼C) MDMs were pre-incubated with 
IFN-γ, 1,25-D3, or both for 18 h with or without L-NMMA or L-NAME. Cells were then infected with MTB H37Ra (MOI=1) for 30 min. 
(A, B) Western blot analysis was performed for IκB-α, p-IKKα/IKKβ, p-ERK1/2, and p-p38. (C) MEK1 assay. Upper panel, Representative gel 
from three independent experiments with similar results is shown. Lower panel, Densitometric assessment of three independent replicates (for 
each experiment) with similar results. (D) RT-PCR analysis for iNOS mRNA. Human MDMs were infected with MTB H37Ra (MOI=1) for 6 
h in the absence or presence of different protein kinase inhibitors [U0126 (5, 10, 20μM), SB203580 (1, 5, 10μM), CAPE (0.1, 1, 10μM), 
or BAY 11-7082 (1, 5, 10μM) for 45 min]. The β-actin mRNA level was used as a control. Upper panel, Representative gel from three 
independent experiments with similar results is shown. Lower panel, Densitometric assessment of four independent replicates (for each experiment) 
with similar results. ***p<0.001 vs. untreated control.
tive experiments shown in Fig. 4A (and in data not shown), 
MTB  H37Ra-  or  PPD-induced  iNOS  protein  expression  was 
significantly inhibited by a specific mAb against TLR2, where-
as  it  was  not  affected  by  anti-TLR4  mAb.  In  addition, 
siRNA-mediated knockdown of TLR2, but not TLR4, resulted 
in diminished MTB H37Ra-induced iNOS protein expression 
(Fig. 4B). The knockdown of TLR2, but not TLR4, also re-
sulted in decreased IκB-α degradation and IKKα/β phos-
phorylation in human MDMs (Fig. 4B). These data indicate 
an essential role for TLR2 in MTB H37Ra-stimulated iNOS in-
duction  by  human  macrophages  primed  with  IFN-γ and 
1,25-D3.
Antimycobacterial activity of combined treatment 
with 1,25-D3 and IFN-γ is not correlated with its effect 
on cathelicidin expression
Recent studies reported that the addition of 1,25-D3 to pri-
mary human MDMs infected with virulent MTB reduced the 
number  of  viable  bacilli  through  the  induction  of  the  anti-
microbial  peptide  cathelicidin  (10).  We  examined  whether Nitric Oxide Synthesis in Human Macrophages
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Figure 4. Induced iNOS expression is dependent on TLR2 but not TLR4. (A) MDMs were pre-incubated with anti-TLR2, anti-TLR4, or isotype-control 
mAbs (10 μg/ml), followed by treatment with IFN-γ, 1,25-D3, or both for 18 h. Cells were then infected with MTB H37Ra (MOI=1) for 18 
h. Western blot analysis was performed using rabbit anti-iNOS Ab. (B) Effects of specific hTLR2 or hTLR4 gene silencing on MTB H37Ra -stimulated 
iNOS expression of human MDMs pretreated with IFN-γ plus 1,25-D3. Gene silencing using shRNAs generated by psiRNA-h7SKGFPzeo plasmids 
was performed by transient transfection using amaxa Nucleofector technology. At 18 h after transfection, the cells were treated with IFN-γ plus 
1,25-D3 for 18 h, followed by stimulation with MTB H37Ra (MOI=1) for 30 min. Cell lysates were prepared and analyzed on Western blots 
for the expression of iNOS, TLR2, TLR4, IkB-α, and p-IKKα/IKKβ. The β-actin level was used as a control. Results are representative of three 
experiments.
combined IFN-γ and 1,25-D3 treatment affected the induc-
tion  of  cathelicidin.  As  shown  in  Fig.  5A,  PPD  stimulation 
strongly  induced  the  expression  of  cathelicidin  mRNA  in 
MDMs treated with 1,25-D3. However, the expression of cath-
elicidin  was  virtually  identica l  b e t w e e n  c e l l s  t r e a t e d  w i t h  
1,25-D3 and cells treated with 1,25-D3 plus IFN-γ (Fig. 5A). 
In  addition,  cathelicidin  expression  was  not  influenced  by 
p r e t r e a t m e n t  w i t h  e i t h e r  L - N M M A  o r  L - N A M E  ( d a t a  n o t  
shown). These data demonstrate that the combined treatment 
with IFN-γ and 1,25-D3 does not act by enhancing the ex-
pression  of  cathelicidin. 
    As a physiological endpoint for gauging the importance of 
iNOS  in  antimycobacterial  defenses,  we  quantitated  intra-
cellular  mycobacterial  growth  using  both  [
3H]-uracil  uptake 
an d   C F U  ass ay s.  To  e st im at e  t he  i nt ra ce ll ul ar in oc u lu m of 
MTB, MDMs were lysed after 1, 4, and 7 days of incubation 
with  bacteria.  Upon  treatment  with  1,25-D3  alone,  virulent 
MTB H37Rv showed reduced survival in MDMs (Fig. 5B and 
C). In CFU assays, combined treatment with 1,25-D3 and IFN-
γ resulted in a 2-fold decrease in the intracellular survival 
of  virulent  MTB  H37Rv,  relative  to  that  seen  with  1,25-D3 
alone (Fig. 5B). The antimycobacterial effect induced by this 
combination was significantly attenuated by pretreatment with 
either  L-NMMA  or  L-NAME  (data  not  shown).  Collectively, 
these  results  suggest  that  iNOS  induction  by  the  combined 
treatment with 1,25-D3 and IFN-γ is sufficient to influence 
intracellular  mycobacterial  growth  during  MTB  infection.
DISCUSSION
The role of iNOS and the factor(s) affecting iNOS induction 
in human macrophages remain unresolved. The present data 
demonstrate that combined treatment with 1,25-D3 and IFN-
γ synergistically enhances PPD- or MTB-induced NO release 
and iNOS expression in human MDMs. In mice, it has been 
shown that iNOS is capable of producing a large amount of 
NO when induced by several mediators as IFN-γ, TNF-α, 
LPS, and several microorganisms (22); however, under similar 
conditions, human macrophages produce either low levels of 
NO (8,23) or none at all (24,25). Recently it was shown that 
alveolar macrophages, but not blood monocytes, are capable 
of producing NO in vitro after stimulation with MTB and its 
secretory antigens (26). Regarding NO induction, our findings 
are  consistent  with  previously  published  data  showing  that 
iNOS expression in monocytes/macrophages in humans does 
not appear to be up-regulated by IFN-γ and TNF-α (17). 
Although stimulation with rhIFN-γ and rhTNF-α (either sep-
arately or together) failed to increase the level of NO, com-
bined  treatment  with  IFN-γ  and  1,25-D3  synergistically 
stimulated the production of NO and iNOS activation in hu-
m a n  M D M s .  C o m b i n e d  1 , 2 5 - D 3  a n d  I F N - γ treatment  may 
represent a physiological cell culture system for the induction 
of iNOS in human macrophages derived from the monocytes 
of healthy donors. Thus, our work establishes an ideal in vi-
tro model environment for modulating the NO-dependent an-
timycobacterial  defenses  of  human  MDMs. Nitric Oxide Synthesis in Human Macrophages
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Figure 5. IFN-γ plus 1,25-D3 induces antimycobacterial activity against
MTB. (A) Densitometric analysis for cathelicidin (LL-37) mRNA ex-
pression in human MDMs stimulated by PPD after an 18-h 
pretreatment with IFN-γ, 1,25-D3, or both. Cathelicidin levels are 
expressed relative to β-actin levels. (B, C) Antimicrobial activity by 
human MDMs pretreated with IFN-γ, 1,25 D3, or both. Cells were
pre-incubated for 18 h and infected with MTB H37Rv (MOI=1). At 
day 7, the number of viable bacteria was assessed by CFU assay. 
Results are representative of seven experiments. (C) At the time points 
shown, the cells were lysed, and [
3H]-uracil incorporation into the 
released bacteria was measured. Results are representative of six 
experiments. *p＜0.05, **p＜0.01, ***p＜0.001 vs. MTB H37Rv- 
treated control.
    Previous  studies  have  suggested  that  a  NO-independent 
pathway is responsible for the direct antimicrobial activity of 
human monocytes/macrophages against intracellular bacteria 
via TLRs (27); however, this conclusion was based on in vitro 
findings  that  may  differ  critically  from  those  with  differ-
entiated macrophages in vivo and ex vivo (11). Our results 
suggest  that  NO  plays  an  indispensable  role  in  human  de-
fenses against mycobacterial infections because the combined 
r e g i m e n ,  w h i c h  w a s  s i g n i f i c a n t l y  m o d u l a t e d  b y  i N O S  i n -
hibitors, significantly suppressed the growth of MTB (see Fig. 
5B  and  C;  data  not  shown).  MTB-infected  human  alveolar 
macrophages are capable of producing NO, which is corre-
lated with intracellular growth inhibition of mycobacteria in 
alveolar  macrophages  (8).  Additionally,  when  macrophages 
expressing iNOS were recovered from patients and infected 
with mycobacteria in vitro, iNOS inhibitors abolished the anti-
mycobacterial  activity  induced  by  the  macrophages  (28).   
Moreover, it was previously demonstrated that stimulation of 
monocytes/ex vivo-matured macrophages from active TB pa-
tients with proinflammatory cytokines leads to NO production 
and lowers the CFU of MTB in these cells (29). Taken togeth-
er, NO may serve directly or indirectly as a mycobactericidal 
mediator  in  human  monocytes/macrophages.
    Our  data  indicate  that  ERK-1/2  and  NF-κB  activation  is 
necessary  for the  modulation of  iNOS  by  combined IFN-γ 
and  1,25-D3  treatment.  Specific  inhibition  of  either  NF-κB 
or the ERK-1/2 pathway revealed the specific role of the NF-
κB  and  ERK-1/2  pathways  in  IFN-γ-inducible  NOS  ex-
pression and NO production in human macrophages (30). In 
addition, ERK-1/2 activation results in Signal transducer and 
activator  of  transcription  1α (STAT1α)  phosphorylation  in 
IFN-γ-stimulated  macrophages,  and  both  ERK-1/2  and Nitric Oxide Synthesis in Human Macrophages
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STAT1α are key players in the IFN-γ-inducible generation 
of NO by macrophages (31). Furthermore, our data indicate 
that  combined  treatment  with  IFN-γ and  1,25-D3  leads  to 
significant  MEK1  activation  and  IKKα/β phosphorylation, 
upstream of  ERK-1/2  and IκBα, respectively. In addition, 
robust activation of MAPK and NF-κB is also dependent on 
iNOS expression in human macrophages, as these signaling 
pathways are also modulated by intracellular NOS inhibitors. 
Thus, our data also indicate a role of NO in mediating the 
regulation of key transcription factors targeted by cellular sig-
naling,  as  suggested  by  previous  studies  (32). 
    This is the first study to demonstrate an indispensable role 
for TLR2 in MTB-stimulated iNOS induction by human macro-
phages primed with IFN-γ and 1,25-D3. Our results confirm 
previous findings regarding vitamin D as a key link between 
TLR activation and antibacterial responses in innate immunity 
(10). Vitamin D3 is known to possess a variety of immuno-
modulatory properties, including effects on both myeloid and 
lymphoid  cells  (33),  and  several  lines  of  evidence  indicate 
that 1,25-D3 regulates host resistance to MTB. Recently, it was 
shown that priming monocytic cells with 1,25-D3 strongly in-
fluences  their  sensitivity  to  LPS  and  different  TLR2  triggers 
[lipoteichoic  acid  (LTA),  trispalmitoyl-cysteyl-seryl-lysyl-lysyl- 
lysyl-lysine  (Pam3Cys)  and  peptidoglycan  (PGN)]  (34). 
Moreover,  1,25-D3 deficiency  and  vitamin  D receptor  poly-
morphisms  have  been  linked  to  increased  susceptibility  to 
MTB and Mycobacterium leprae (35-37), and in murine stud-
ies, 1,25-D3 has been shown to activate the antimycobacterial 
activities  of  mononuclear  phagocytes  (38,39). 
    Furthermore, a direct correlation exists between the levels 
of IFN-γ and 1,25-D3 in the pleural spaces, which suggests 
that  IFN-γ is  an  important  peripleural  regulator  of  macro-
phage 1,25-D3 synthesis (40). Moreover, exposure of primary 
monocytes, alveolar macrophages, or monocytic THP-1 cells 
to  IFN-γ markedly  enhances  macrophage  1,25-D3  produc-
tion (41), suggesting that cross-talk occurs between the cyto-
kine and 1,25-D3. Thus, our data provide additional strong 
evidence  that  the  vitamin  D-mediated  antimicrobial  mecha-
nism in human macrophages is likely augmented by T cell- 
dependent  adaptive  immune  mechanisms,  including  signals 
for  macrophage  activation  by  cytokines,  especially  IFN-γ.
    It  is  presently  unclear  why  combined  treatment  with 
1,25-D3 and IFN-γ did not produce a synergistic effect on 
nitrite production in 96-h cultures, as measured by the Griess 
method,  given  its  effects  on  NO  production  and  iNOS  ex-
pression (Fig. 2A∼C). As IFN-γ and 1,25-D3 show potential 
superoxide anion-generating activity upon the stimulation of 
human monocytic cells (42), we asked whether  stimulation 
with 1,25-D3, IFN-γ, or both could elicit the generation of 
superoxide  in  human  MDMs.  We  found  that  IFN-γ sig-
nificantly enhanced superoxide anion generation in 1,25-D3- 
treated MDMs (data not shown). NO is a short-lived diatomic 
free-radical species synthesized by NOS that reacts with su-
peroxide anion to form reactive peroxinitrite (OONO-) (43). 
Therefore,  the  antimycobacterial  activities  induced  by  the 
combination of 1,25-D3 and IFN-γ may also be attributable 
to the generation of a potent oxidant, such as peroxinitrite, 
by superoxide and NO. Further studies are necessary to re-
veal the precise mechanisms by which the combined regimen 
activates antimycobacterial activities related to the generation 
of  reactive  oxygen  and  nitrogen  species.
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